← Back to Clinical Trials
Recruiting NCT06742450

Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Parkinson's Disease (PD)
Sponsor Xuanwu Hospital, Beijing
Study Type INTERVENTIONAL
Phase N/A
Enrollment 180
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2024-01-27
Completion 2026-03-31
Interventions
Constant current (CC) subthalamic nucleus deep brain stimulationConstant voltage (CV) subthalamic nucleus deep brain stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To compare the efficacy, programming burden, power consumption, and physicians' and patients' satisfaction between current mode and voltage mode of deep brain stimulation in each period one year after surgery.

Eligibility Criteria

Inclusion Criteria: * Patients with idiopathic Parkinson's disease * Aged 18 to 75, no limited sex * After bilateral STN-DBS, yet not powered on Exclusion Criteria: * Mental disorders or dementia * Pregnant, lactating women or women who are unable to take effective measures to prevent pregnancy * Serious health conditions, such as tumors, liver or kidney diseases, etc. * Epilepsy or other seizure disorders * Patients with severely deviated electrode placement * Patients who were unable to voluntarily sign an informed consent form * Patients who did not agree to cooperate with follow-up

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}